Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK details medtech spending in NHS Plan delivery report

This article was originally published in Clinica

Executive Summary

The UK National Health Service spent almost £54.5bn ($86bn) in 2002-03, up £5.2bn on the previous year, and plans to spend almost £1bn more on staff and equipment in 2003-04. According to Delivering the NHS Plan: Expenditure Report, published earlier this month, the benefits of last year's spending include new cardiac diagnostic and treatment equipment worth £35m; work on more than 40 cardiac catheterisation laboratories (£20m); the installation of 680 public-access automatic external defibrillators (AEDs); and extending the breast cancer screening programme to cover a further 120,000 women since April 2002.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT061922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel